Ibritumomab tiuxetan

From WikiMD's free health, diet & wellness encyclopedia
Jump to navigation Jump to search

ibritumomab tiuxetan

 (ih-brih-TOO-moh-mab ty-UK-seh-tan)A drug used to treat certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Ibritumomab tiuxetan contains a monoclonal antibody that binds to a protein called CD20, which is found on B cells and some types of lymphoma cells. It also contains the compound tiuxetan, which allows certain radioactive substances to be attached to the monoclonal antibody. This may help kill cancer cells. Ibritumomab tiuxetan is a type of monoclonal antibody and a type of immunoconjugate. Also called Zevalin.



Latest research - Ibritumomab tiuxetan

PubMed
Clinical trials


 

Ibritumomab tiuxetan is part of WikiMD's free ^articles!

^Ibritumomab tiuxetan (article) is provided for informational purposes only. No expressed or implied warranties as to the validity of content.
WikiMD is not a substitute for professional advice. By accessing and using WikiMD you agree to the terms of use.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.
W8MD weight loss logo

Ad. Tired of being overweight?. W8MD's physician weight loss program can HELP. Tele medicine available